Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...

A new study published in the journal of Risk Management and Healthcare Policy showed that the frequency of magnesium ...

Chemists from Tomsk Polytechnic University, as part of an international team, have obtained unique crystals that exhibit ...

Hemostasis Market Insight, Epidemiology and Market Forecast - 2032The hemostasis market is experiencing significant expansion, driven by inc ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

In a dramatic escalation of what experts now call a full-blown “spy war,” the United States and China are rapidly intensifying their covert operations against each other. The recent arrest of a ...

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a ...

In a remarkable achievement that is already impacting how we detect and diagnose disease, UK Biobank has completed the world's largest whole body imaging project, scanning the brains, hearts, abdomens ...

Wearable healthcare devices, such as glucose monitors and heart monitors, are popular due to their ability to gather real-time data that supports users' health and safety.

Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...

The rapid lateral flow assay from Lumos Diagnostics distinguishes bacterial and nonbacterial respiratory infections using a drop of blood.

Plaisio invests in the new generation and takes them on a unique experience of knowledge and innovation through the robotics ...